The disbursement will bolster the company’s manufacturing capabilities and foster product diversification, including complex generics The grant emphasises the company’s commitment to driving innovation, entitles it to incentives for incremental sales of eligible pharmaceutical products Venus Remedies Ltd, one of India’s leading manufacturers of generic
Quote for International Women’s Day from Priyanka Chigurupati, Executive Director, Granules India Ltd. "As we commemorate International Women's Day, it's important to recognize the strides we have made towards gender equality yet acknowledge that we have miles to go. In the pharmaceutical industry, we are at
Emerges as the ONLY Healthcare Marketing Platform that ensures Real-Time Programmatic message delivery across POC platforms triggered by clinical data, AT SCALE The largest global marketing platform to reach 5 M+ HCPs across 25+ countries through 4000+ marketing campaigns Doceree, the leading global healthcare
Indian pharma companies are incorporating AI algorithms into their R&D operations, clinical trials and streamlining processes Firms deploying GenAI are seeing reduction in early-stage drug development costs, and improvement in operational efficiencies EY Parthenon (EY-P), the leading strategy consulting firm, in partnership with BioAsia,
Biological E. Limited (BE) to Manufacture Up to 50 Million Doses of QDENGA Per Year, Accelerating Takeda’s Ability to Deliver 100 Million Doses Per Year by 2030 At the Latest Addresses the Specific Need to Offer Multi-Dose Vials for National Immunization Programs to
Aparna Pharmaceuticals Private Limited, a leader in manufacturing Active Pharmaceutical Ingredients (APIs) and Advanced Drug Intermediates, is pleased to announce that its manufacturing facility, Aparna Organics Limited, located in Pydibhimavaram, Srikakulalam, Andhra Pradesh, India has received VAI classification from the United States Food and Drug
This GMP certification for the company’s production facilities has added to its portfolio of international approvals from 25 regulators The recognition demonstrates Venus Remedies’ persistence in adhering to stringent manufacturing standards and providing greater access to life-saving drugs in the African continent Venus Remedies, a
Thermo Fisher Scientific, the world leader in serving science, has once again secured its position among India’s top 15 Best Workplaces in the Pharmaceutical, Healthcare and Biotech industry, as announced by the prestigious Great Place to Work® organization in India. This marks the third consecutive
Venus Remedies makes its maiden entry into Azerbaijan’s pharmaceutical market The company has over a dozen marketing authorisations for enoxaparin worldwide Venus Remedies Limited, a leading fixed-dosage injectable manufacturer, has reached a significant milestone with a marketing authorisation from Azerbaijan for the first time for
Venus Remedies has secured regulatory approval from Philippines for chemotherapy medication paclitaxel and zoledronic acid, a drug used to treat metabolic bone disorders The company has also received marketing authorisation for another chemotherapy drug, bleomycin, from Saudi Arabia While Saudi Arabia is the largest
